Drug-Drug Interactions of Direct Oral Anticoagulants (DOACs): From Pharmacological to Clinical Practice

The direct oral anticoagulants (DOACs), dabigatran, rivaroxaban, apixaban, and edoxaban, are becoming the most commonly prescribed drugs for preventing ischemic stroke in patients with non-valvular atrial fibrillation (NVAF) and for the treatment and prevention of venous thromboembolism (VTE). Rivar...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Nicola Ferri, Elisa Colombo, Marco Tenconi, Ludovico Baldessin, Alberto Corsini
Format:	Artigo
Jezik:	Inglês
Izdano:	MDPI AG 2022-05-01
Serija:	Pharmaceutics
Teme:	apixaban dabigatran rivaroxaban edoxaban drug-drug interaction pharmacokinetics
Online dostop:	https://www.mdpi.com/1999-4923/14/6/1120
Oznake:	Označite Brez oznak, prvi označite!